These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
465 related articles for article (PubMed ID: 32803569)
21. Air pollutants and development of interstitial lung disease in patients with connective tissue disease: a population-based case-control study in Taiwan. Chen HH; Yong YM; Lin CH; Chen YH; Chen DY; Ying JC; Chao WC BMJ Open; 2020 Dec; 10(12):e041405. PubMed ID: 33372076 [TBL] [Abstract][Full Text] [Related]
22. Targeting CD20 in the treatment of interstitial lung diseases related to connective tissue diseases: A systematic review. Bellan M; Patrucco F; Barone-Adesi F; Gavelli F; Castello LM; Nerviani A; Andreoli L; Cavagna L; Pirisi M; Sainaghi PP Autoimmun Rev; 2020 Feb; 19(2):102453. PubMed ID: 31838163 [TBL] [Abstract][Full Text] [Related]
23. Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature. Ferri C; Manfredi A; Sebastiani M; Colaci M; Giuggioli D; Vacchi C; Della Casa G; Cerri S; Torricelli P; Luppi F Autoimmun Rev; 2016 Jan; 15(1):61-70. PubMed ID: 26384526 [TBL] [Abstract][Full Text] [Related]
24. Interstitial lung disease in patients with connective tissue disease: Subtypes, clinical features and comorbidities in the Western Cape, South Africa. Palalane E; Alpizar-Rodriguez D; Botha S; Said-Hartley Q; Calligaro G; Hodkinson B Afr J Thorac Crit Care Med; 2022; 28(2):. PubMed ID: 36034053 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of rheumatoid arthritis and connective tissue disease-related interstitial lung disease with pulmonary physiologic test, HRCT, and patient-based measures of dyspnea and functional disability. Topcu A; Mursaloglu HH; Yalcinkaya Y; Karakurt S; Yagiz B; Alaca Z; Demir M; Coskun BN; Dalkilic E; Inanc N Clin Rheumatol; 2021 Sep; 40(9):3797-3805. PubMed ID: 33811590 [TBL] [Abstract][Full Text] [Related]
27. The correlation between miR-200c and the severity of interstitial lung disease associated with different connective tissue diseases. Jiang Z; Tao JH; Zuo T; Li XM; Wang GS; Fang X; Xu XL; Li XP Scand J Rheumatol; 2017 Mar; 46(2):122-129. PubMed ID: 27309544 [TBL] [Abstract][Full Text] [Related]
29. Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study. Cao M; Sheng J; Qiu X; Wang D; Wang D; Wang Y; Xiao Y; Cai H BMC Pulm Med; 2019 Nov; 19(1):215. PubMed ID: 31727051 [TBL] [Abstract][Full Text] [Related]
30. Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a systematic review and meta-analysis. Joy GM; Arbiv OA; Wong CK; Lok SD; Adderley NA; Dobosz KM; Johannson KA; Ryerson CJ Eur Respir Rev; 2023 Mar; 32(167):. PubMed ID: 36889782 [TBL] [Abstract][Full Text] [Related]
31. Diagnosis and treatment of connective tissue disease-associated interstitial lung disease. Vij R; Strek ME Chest; 2013 Mar; 143(3):814-824. PubMed ID: 23460159 [TBL] [Abstract][Full Text] [Related]
32. Management of interstitial lung disease associated with connective tissue disease. Mathai SC; Danoff SK BMJ; 2016 Feb; 352():h6819. PubMed ID: 26912511 [TBL] [Abstract][Full Text] [Related]
33. Lung-dominant connective tissue disease among patients with interstitial lung disease: prevalence, functional stability, and common extrathoracic features. Pereira DA; Dias OM; Almeida GE; Araujo MS; Kawano-Dourado LB; Baldi BG; Kairalla RA; Carvalho CR J Bras Pneumol; 2015; 41(2):151-60. PubMed ID: 25972968 [TBL] [Abstract][Full Text] [Related]
34. The value of serum Krebs von den lungen-6 as a diagnostic marker in connective tissue disease associated with interstitial lung disease. Ma H; Lu J; Song Y; Wang H; Yin S BMC Pulm Med; 2020 Jan; 20(1):6. PubMed ID: 31915006 [TBL] [Abstract][Full Text] [Related]
35. Interstitial lung disease in systemic autoimmune rheumatic diseases: a comprehensive review. Atzeni F; Gerardi MC; Barilaro G; Masala IF; Benucci M; Sarzi-Puttini P Expert Rev Clin Immunol; 2018 Jan; 14(1):69-82. PubMed ID: 29202589 [TBL] [Abstract][Full Text] [Related]
36. Clinical significance of interleukin-6, total bilirubin, CD3 + CD4 + T cells counts in the acute exacerbation of connective tissue disease-associated interstitial lung disease: a cross-sectional study. Ma C; Meng K; Shi S; Zhao T; Chen S; Zhou X; Shu R; Ma M; Tian M; Ding J Eur J Med Res; 2023 Sep; 28(1):393. PubMed ID: 37773193 [TBL] [Abstract][Full Text] [Related]
37. Current and Emerging Drug Therapies for Connective Tissue Disease-Interstitial Lung Disease (CTD-ILD). Jee AS; Corte TJ Drugs; 2019 Sep; 79(14):1511-1528. PubMed ID: 31399860 [TBL] [Abstract][Full Text] [Related]
38. Clinical features and outcome of acute exacerbation in connective tissue disease-associated interstitial lung disease: A single-center study from India. Singh P; Thakur B; Mohapatra AK; Padhan P Int J Rheum Dis; 2019 Sep; 22(9):1741-1745. PubMed ID: 31328423 [TBL] [Abstract][Full Text] [Related]
39. Serum MUC5AC protein levels are correlated with the development and severity of connective tissue disease-associated pulmonary interstitial lesions. Weng L; Liu W; Wang L; Wu Z; Liu D; Lin Y; Song S; Yu C; Chen Y; Chen J; Ge S Front Immunol; 2022; 13():987723. PubMed ID: 36189284 [TBL] [Abstract][Full Text] [Related]
40. Treatment of connective tissue disease-associated interstitial lung disease: the pulmonologist's point of view. Koo SM; Uh ST Korean J Intern Med; 2017 Jul; 32(4):600-610. PubMed ID: 28704913 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]